Cargando…

Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective

Infused biologics, such as pegloticase, are a core component of managing uncontrolled gout, which is increasing in prevalence. Pegloticase is often the last line of therapy for patients with uncontrolled gout; therefore, achieving a successful course of treatment is critical. The infusion nurse'...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Britni, Sanders, Shayla, Patel, Shilpa A., Martin, Andrea, West, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306337/
https://www.ncbi.nlm.nih.gov/pubmed/37406337
http://dx.doi.org/10.1097/NAN.0000000000000510
_version_ 1785065914350174208
author Baxter, Britni
Sanders, Shayla
Patel, Shilpa A.
Martin, Andrea
West, Michael
author_facet Baxter, Britni
Sanders, Shayla
Patel, Shilpa A.
Martin, Andrea
West, Michael
author_sort Baxter, Britni
collection PubMed
description Infused biologics, such as pegloticase, are a core component of managing uncontrolled gout, which is increasing in prevalence. Pegloticase is often the last line of therapy for patients with uncontrolled gout; therefore, achieving a successful course of treatment is critical. The infusion nurse's role in patient education, serum uric acid monitoring, and patient medication compliance is essential for ensuring patient safety and maximizing the number of patients who benefit from a full treatment course of pegloticase. Infusion nurses are on the front lines with patients and need to be educated on potential negative effects associated with the medications they infuse, such as infusion reactions, as well as risk management methods like patient screening and monitoring. Further, patient education provided by the infusion nurse plays a large role in empowering the patient to become their own advocate during pegloticase treatment. This educational overview includes a model patient case for pegloticase monotherapy, as well as one for pegloticase with immunomodulation and a step-by-step checklist for infusion nurses to refer to throughout the pegloticase infusion process. A video abstract is available for this article at http://links.lww.com/JIN/A105.
format Online
Article
Text
id pubmed-10306337
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-103063372023-06-30 Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective Baxter, Britni Sanders, Shayla Patel, Shilpa A. Martin, Andrea West, Michael J Infus Nurs Features Infused biologics, such as pegloticase, are a core component of managing uncontrolled gout, which is increasing in prevalence. Pegloticase is often the last line of therapy for patients with uncontrolled gout; therefore, achieving a successful course of treatment is critical. The infusion nurse's role in patient education, serum uric acid monitoring, and patient medication compliance is essential for ensuring patient safety and maximizing the number of patients who benefit from a full treatment course of pegloticase. Infusion nurses are on the front lines with patients and need to be educated on potential negative effects associated with the medications they infuse, such as infusion reactions, as well as risk management methods like patient screening and monitoring. Further, patient education provided by the infusion nurse plays a large role in empowering the patient to become their own advocate during pegloticase treatment. This educational overview includes a model patient case for pegloticase monotherapy, as well as one for pegloticase with immunomodulation and a step-by-step checklist for infusion nurses to refer to throughout the pegloticase infusion process. A video abstract is available for this article at http://links.lww.com/JIN/A105. Wolters Kluwer Health, Inc. 2023-07-06 2023-07 /pmc/articles/PMC10306337/ /pubmed/37406337 http://dx.doi.org/10.1097/NAN.0000000000000510 Text en © 2023 The Authors. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Features
Baxter, Britni
Sanders, Shayla
Patel, Shilpa A.
Martin, Andrea
West, Michael
Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
title Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
title_full Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
title_fullStr Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
title_full_unstemmed Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
title_short Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
title_sort pegloticase in uncontrolled gout: the infusion nurse perspective
topic Features
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306337/
https://www.ncbi.nlm.nih.gov/pubmed/37406337
http://dx.doi.org/10.1097/NAN.0000000000000510
work_keys_str_mv AT baxterbritni pegloticaseinuncontrolledgouttheinfusionnurseperspective
AT sandersshayla pegloticaseinuncontrolledgouttheinfusionnurseperspective
AT patelshilpaa pegloticaseinuncontrolledgouttheinfusionnurseperspective
AT martinandrea pegloticaseinuncontrolledgouttheinfusionnurseperspective
AT westmichael pegloticaseinuncontrolledgouttheinfusionnurseperspective